FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1160-1162 October 27, 1994 Number 17 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Hayes, M. A. PubMed Citation

To the Editor: The study by Hayes et al. (June 16 issue)¹ demonstrates that excessive doses of adrenergic agents (dobutamine alone or in combination with norepinephrine) may result in altered tissue function and increased mortality rates among critically ill patients. One should not infer from this study, however, that dobutamine should be avoided as a means of increasing oxygen delivery in some groups of critically ill patients or that attempts to optimize oxygen delivery in relation to the metabolic demands of the critically ill should be discouraged.

Two important issues must be considered. First, even though nearly half the patients . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.